<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-044482</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Proptosis as the first signo of recurrent scirrhous breast carcinoma</dc:title>
<dc:description xml:lang="en">Objective: To inform clinicians of a metastatic orbital neoplasm that frequently masquerades as an orbital inflammatory syndrome. Case report: The case of a 61-year-old woman, diagnosed and treated seven years ago for a scirrhous breast carcinoma is presented. She complained of blurred vision and proptosis of the left eye and these symptoms were the first manifestation of tumor relapse. Discussion: When orbital inflammation is detected in an adult female patient, a full medical history must be obtained and physical examination performed, as orbital metastases have been reported to be the initial manifestation of malignancy in 30 to 50% of cases</dc:description>
<dc:creator>Cristóbal-Bescós, J. A</dc:creator>
<dc:creator>Domínguez-Polo, A. M</dc:creator>
<dc:creator>Rodríguez-Marco, N. A</dc:creator>
<dc:creator>Castillo-Laguarta, J</dc:creator>
<dc:creator>Sierra-barreras, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Informar a los clínicos que las metástasis orbitarias son con frecuencia catalogadas de síndromes inflamatorios.Caso clínico: Se presenta el caso de una mujer de 61 años diagnosticada y tratada siete años antes de un carcinoma escirro de mama. La paciente aquejaba visión borrosa y proptosis en su ojo izquierdo como primera manifestación de la recidiva tumoral.Discusión: Cuando se diagnostica una inflamación orbitaria en una paciente mujer adulta, se debe realizar una meticulosa historia clínica, debido a que las metástasis orbitarias han sido descritas como manifestación inicial de malignidad en el 30 a 50% de los casos</dc:description>
<dc:source>Arch Soc Esp Oftalmol;80(12): 737-740, dic. 2005. ilus</dc:source>
<dc:identifier>ibc-044482</dc:identifier>
<dc:title xml:lang="es">Proptosis como primera manifestación de recidiva de cáncer escirro de mama</dc:title>
<dc:subject>^d31803^s22016</dc:subject>
<dc:subject>^d1968^s22016</dc:subject>
<dc:subject>^d22589^s22064</dc:subject>
<dc:subject>^d22589^s22057</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d31803^s22064</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d24375</dc:subject>
<dc:subject>^d31803^s22057</dc:subject>
<dc:subject>^d28010^s22016</dc:subject>
<dc:subject>^d1968^s22053</dc:subject>
<dc:subject>^d31474</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d22589^s22016</dc:subject>
<dc:subject>^d1968^s22057</dc:subject>
<dc:subject>^d974^s22073</dc:subject>
<dc:subject>^d9557^s22053</dc:subject>
<dc:type>article</dc:type>
<dc:date>200512</dc:date>
</metadata>
</record>
</ibecs-document>
